Surgery – Blood drawn and replaced or treated and returned to body – Constituent removed from blood and remainder returned to body
Reexamination Certificate
2011-03-29
2011-03-29
Deak, Leslie R (Department: 3761)
Surgery
Blood drawn and replaced or treated and returned to body
Constituent removed from blood and remainder returned to body
C604S006160, C604S096010
Reexamination Certificate
active
07914478
ABSTRACT:
An intra pelvic cancer therapeutic agent perfusion apparatus and method for administering a cancer therapeutic agent to and recovering same from a cancer tissue site within the pelvis. The tip of a first sheath is percutaneously inserted into the femoral artery and the tip of a second sheath is inserted into the femoral vein. A first balloon catheter is inserted into the aorta through the femoral artery and a second balloon catheter is inserted into the vena cava through the femoral vein. The first balloon catheter is used to block the blood flow and the second balloon is inflated to form an intravenous closed region between the site of insertion in the vena cava and a lower limb side venous site. A body fluid containing a cancer therapeutic agent is administered to the intra arterial closed region through the first sheath and is removed therefrom through the second sheath.
REFERENCES:
patent: 5069662 (1991-12-01), Bodden
patent: 5817046 (1998-10-01), Glickman
patent: 6699231 (2004-03-01), Sterman et al.
Regional perfusion of the pelvis: consideration of the “leakage” problem. Lawrence et al. Surgery, vol. 50, No. 1. pp. 248-259. Jul. 1961.
Treatment of malignant pelvic tumors by extracorporeal perfusion with chemotherapeutic agents. Austen et al. Journal of Medicine, vol. 261, No. 21. Nov. 19, 1959.
Regional Chemotherapy for Cancer: Experiences with 116 Perfusions. Stehlin et al. Annals of Surgery, vol. 151, No. 4. pp. 605-619. Apr. 1960.
Isolated Pelvic Perfusion for Unresectable Cancer Using a Balloon Occlusion Technique. Turk et al. Arch Surg, vol. 128, pp. 533-539. May 1993.
Pharmacokinetic model and the clinical pharmacology of cis-platinum, fluorouracil and mitomycin-C in isolated pelvic perfusion. Wanebo et al. Cancer Chemother Pharmacol., 43: 427-434. 1999.
Preoperative Therapy for Advanced Pelvic Malignancy by Isolated Pelvic Perfusion with the Bolloon-Occlusion Technique. Wanebo et al. Annals of Surgical Oncology, 3(3):295-303, 1996.
Chemotherapy of Cancer: Regional Perfusion Utilizing an Extracorporeal Circuit. Creech, Jr. et al. Annals of Surgery, vol. 148, No. 4. pp. 616-632. Oct. 1958.
Kumazaki Tatsuo
Murata Satoru
Bacon & Thomas PLLC
Deak Leslie R
LandOfFree
Intrapelvic perfusion therapy with cancer therapeutic agent... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intrapelvic perfusion therapy with cancer therapeutic agent..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intrapelvic perfusion therapy with cancer therapeutic agent... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2661646